Z

Zhongyan Shan

First Hospital of China Medical University

ORCID: 0000-0002-2849-2380

489 papers and 21.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#7 Current Senior Leader in Thyroid Disorders and Treatments

489Publications

21.6kTotal Citations

#7in Thyroid Disorders and Treatments

First publication: 1996First senior author: 1996

Top publicationsby citations

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma

Ming Gao, Published by the European Mathematical Society with the support of the Schweizerische Akademie der Naturwissenschaften and the Stiftung zur Förderung der mathematischen Wissenschaften in der Schweiz., Yi Pan et al.|Cancer Biology and Medicine|2017

Cited by 124

The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy

Weiwei Wang, Wei Liu, Weiping Teng et al.|European Journal of Endocrinology|2010

Cited by 122

Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study

Xiang Li, Jianping Weng, Zhangrong Xu et al.|Journal of Diabetes Investigation|2018

Cited by 59

Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)

Wen Xu, Jianping Weng, Yan Bi et al.|Journal of Internal Medicine|2014

Cited by 59

Growth arrest-specific protein 6 (Gas6) attenuates inflammatory injury and apoptosis in iodine-induced NOD.H-2h4 mice

Xuren Sun, Weiping Teng, Haixia Guan et al.|International Immunopharmacology|2019

Cited by 11

Indexing the rest of 489 publications…